Home | Diagnosis |  Treatment | Control | TB and HIV  | Drug resistance  | Ind J Tub | FAQ | Links | Email  | About
tbindia Objectives
  • Disseminate info on TB in India
  • Improve care of TB patients in India
  • Enable doctors and NGO's interested in TB control to interact
Search this site or the web powered by FreeFind

Site search Web search

Free Message Forum from Bravenet.com 
Private practitioners:How can private practitioners in India support and encourage governmental efforts on tuberculosis control?What schemes are available
Read it here
Slide show on DOTS

Prevalence figures of TB in India		 spaceIndian Journal of tuberculosis
 
Abstracts from july 2008
Reproduced with kind permission

Editorial

TB control Programme-A way forward

Original articles

  • Evaluation of different types of chest symptoms for diagnosing Pulmonary tuberculosis cases in community surveys
  • DOTS in drug addicts with TB:Delhi experience
  • Is the quality of life different in patients with active and inactive tuberculosis?
  • Relationship of Nitric Oxide and Protein Carbonyl in Tuberculosis
  • Status report on RNTCP

Case reports

  • Scapholunate dissociation :A rare presentation of TB wrist in a case of multi-focal skeletal tuberculosis
  • An unusual case of pleural effusion with an abdominal mass

Short communication

  • Annual risk of Tuberculosis infection in Chennai city
Only abstracts of the issues after Jan 2004 are on line in this site
Click here for list of articles for which abstracts are available
features on treatment categories,drug resistance,self assessment on TB
  • Online help to find the treatment category
  • Self assessment with online quiz
  • Slide show on drug resistance
  • Detailed articles on TB-HIV and MDR-TB
  • FAQ

News and Journal scan
   Rapid Direct Detection and Susceptibility Testing of the Mycobacterium tuberculosis Complex for Isoniazid and Rifampin in Smear Positive Clinical Specimens by the PCR-based Genotype MTBDR Assay.
  Rifapentine for the treatment of pulmonary tuberculosis
  An official ATS statement: hepatotoxicity of antituberculosis therapy.
   Detection of Multi-Drug Resistance in Mycobacterium tuberculosis.
  Click here

Although every precaution has been taken in the preparation of this site, the author assumes no responsibility for errors or omisssions.Neither is any liability assumed for damages resulting from the use of the information contained herein

menu script( for pages other than index) from Dynamicdrive Sitemap